These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36844131)

  • 21. Bilateral tibial Brodie's abscess in a young patient treated with BAG-S53P4: case report.
    Cossio A; Graci J; Lombardo AS; Turati M; Melzi ML; Bigoni M; Zatti G
    Ital J Pediatr; 2019 Jul; 45(1):91. PubMed ID: 31349859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive glass, a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up.
    Rodríguez Á; Parra G; Cuervas-Mons M
    Foot (Edinb); 2021 Sep; 48():101831. PubMed ID: 34390944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Bioactive Glass S53P4 as a Treatment for Diabetic Foot Osteomyelitis.
    De Giglio R; Di Vieste G; Mondello T; Balduzzi G; Masserini B; Formenti I; Lodigiani S; Pallavicini D; Pintaudi B; Mazzone A
    J Foot Ankle Surg; 2021; 60(2):292-296. PubMed ID: 33358382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot.
    Kastrin M; Urbančič Rovan V; Frangež I
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
    Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A
    Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A RETROSPECTIVE CASE-SERIES ON THE USE OF S53P4 BIOACTIVE GLASS FOR THE ADJUNCTIVE TREATMENT OF SEPTIC DIAPHYSEAL NON-UNION.
    Gaiarsa GP; Dos Reis PR; Kojima KE; Silva JS; Lima ALLM
    Acta Ortop Bras; 2019; 27(5):273-275. PubMed ID: 31839738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4.
    Geurts J; van Vugt T; Thijssen E; Arts JJ
    Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31574970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA; Geurts J; Hulsen DJ; van Rietbergen B; Hofmann S; Arts JJ
    Biomed Res Int; 2015; 2015():684826. PubMed ID: 26504821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot Experience on the Use of S53P4 Bioactive Glass in the Surgical Management of Diabetic Foot Osteomyelitis.
    Iacopi E; Pieruzzi L; Goretti C; Piaggesi A
    Int J Low Extrem Wounds; 2022 Mar; 21(1):57-64. PubMed ID: 32506987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5.
    Zhou P; Garcia BL; Kotsakis GA
    BMC Microbiol; 2022 Sep; 22(1):212. PubMed ID: 36050654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S53P4 bioactive glass scaffolds induce BMP expression and integrative bone formation in a critical-sized diaphysis defect treated with a single-staged induced membrane technique.
    Eriksson E; Björkenheim R; Strömberg G; Ainola M; Uppstu P; Aalto-Setälä L; Leino VM; Hupa L; Pajarinen J; Lindfors NC
    Acta Biomater; 2021 May; 126():463-476. PubMed ID: 33774197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Composition dependent mechanical behaviour of S53P4 bioactive glass putty for bone defect grafting.
    van Gestel NAP; Hulsen DJW; Geurts J; Hofmann S; Ito K; Arts JJ; van Rietbergen B
    J Mech Behav Biomed Mater; 2017 May; 69():301-306. PubMed ID: 28131065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multicenter Retrospective Case Review of Outcomes and Complications of S53P4 Bioactive Glass.
    G Leonard C; McNally S; Adams M; Hampton S; McNaboe E; E Reddy CE; A Bailie N
    J Int Adv Otol; 2021 May; 17(3):234-238. PubMed ID: 34100748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regeneration of Cystic Bone Cavities and Bone Defects With Bioactive Glass S53P4 in the Upper and Lower Jaws.
    Stoor P; Apajalahti S; Kontio R
    J Craniofac Surg; 2017 Jul; 28(5):1197-1205. PubMed ID: 28538076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.
    Steinhausen E; Lefering R; Glombitza M; Brinkmann N; Vogel C; Mester B; Dudda M
    J Bone Jt Infect; 2021; 6(4):73-83. PubMed ID: 34084694
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioactive glass as dead space management following debridement of type 3 chronic osteomyelitis.
    Oosthuysen W; Venter R; Tanwar Y; Ferreira N
    Int Orthop; 2020 Mar; 44(3):421-428. PubMed ID: 31701158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Evaluation of Bioactive Glass Putty and Platelet Rich Fibrin in the Treatment of Human Periodontal Intrabony Defects: A Randomized Control Trial.
    Naqvi A; Gopalakrishnan D; Bhasin MT; Sharma N; Haider K; Martande S
    J Clin Diagn Res; 2017 Jul; 11(7):ZC09-ZC13. PubMed ID: 28893033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.
    Sarin J; Grénman R; Aitasalo K; Pulkkinen J
    Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):563-9. PubMed ID: 23012893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.
    Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
    Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33921929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.